Wildcat Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Wildcat Capital Management’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-65,209	Closed	-$1.05M	–	33
2020 Q4	$1.05M	Sell	65,209 -29,478	-31%	-$365K	0.13%	18
2020 Q3	$884K	Hold	94,687	–	–	0.28%	17
2020 Q2	$932K	Hold	94,687	–	–	0.32%	22
2020 Q1	$873K	Sell	94,687 -125,288	-57%	-$1.51M	0.4%	16
2019 Q4	$3.41M	Hold	219,975	–	–	0.98%	19
2019 Q3	$2.08M	Buy	+219,975	New	+$1.91M	0.88%	21

Wildcat Capital Management's UROV Position: Q1 2021 in Review

Wildcat Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 65,209 shares — an estimated $1.05M sold.

Wildcat Capital Management first reported a position in UROV in Q3 2019 and held it in 6 quarters. The position peaked at $3.41M in Q4 2019. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Wildcat Capital Management reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Wildcat Capital Management sold 65,209 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.05M.
Wildcat Capital Management first reported a position in Urovant Sciences Ltd. in Q3 2019 and held it in 6 quarters.
Wildcat Capital Management's Urovant Sciences Ltd. position peaked at $3.41M in Q4 2019.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Wildcat Capital Management's 13F filing for Q1 2021, filed 17 May 2021.